SE8204810L - Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a - Google Patents

Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a

Info

Publication number
SE8204810L
SE8204810L SE8204810D SE8204810D SE8204810L SE 8204810 L SE8204810 L SE 8204810L SE 8204810 D SE8204810 D SE 8204810D SE 8204810 D SE8204810 D SE 8204810D SE 8204810 L SE8204810 L SE 8204810L
Authority
SE
Sweden
Prior art keywords
procedure
dna molecule
hybrid dna
transformed microorganism
make protein
Prior art date
Application number
SE8204810D
Other languages
English (en)
Swedish (sv)
Other versions
SE8204810D0 (sv
Inventor
S Lofdahl
M Uhlen
M Lindberg
Original Assignee
Pharmacia Fine Chemicals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Fine Chemicals Ab filed Critical Pharmacia Fine Chemicals Ab
Publication of SE8204810D0 publication Critical patent/SE8204810D0/xx
Publication of SE8204810L publication Critical patent/SE8204810L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
SE8204810D 1982-08-23 1982-08-23 Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a SE8204810L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8204810A SE462046C (sv) 1982-08-23 1982-08-23 Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma

Publications (2)

Publication Number Publication Date
SE8204810D0 SE8204810D0 (sv) 1982-08-23
SE8204810L true SE8204810L (sv) 1984-02-24

Family

ID=20347592

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8204810D SE8204810L (sv) 1982-08-23 1982-08-23 Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
SE8204810A SE462046C (sv) 1982-08-23 1982-08-23 Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8204810A SE462046C (sv) 1982-08-23 1982-08-23 Hybrid-DNA-vektor innehållande DNA-sekvens från Staphylococcus aureus, förfarande för dess framställning och bakterie innehållande densamma

Country Status (4)

Country Link
JP (1) JPH0755153B2 (OSRAM)
DE (1) DE3390105T1 (OSRAM)
SE (2) SE8204810L (OSRAM)
WO (1) WO1984000773A1 (OSRAM)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
CA1311429C (en) * 1983-07-06 1992-12-15 Vasantha Nagarajan Vector for polypeptides in bacilli
US4801537A (en) * 1984-06-08 1989-01-31 Genex Corporation Vector for expression of polypeptides in bacilli
JPH07108224B2 (ja) * 1985-11-07 1995-11-22 重三 鵜高 バチルス・ブレビスを用いる遺伝子の発現方法
WO1988009343A1 (fr) * 1987-05-29 1988-12-01 Sagami Chemical Research Center Proteine fusionnee contenant une lymphotoxine
WO1989004675A1 (en) * 1987-11-20 1989-06-01 Creative Biomolecules, Inc. Selective removal of immune complexes
US5243040A (en) * 1987-11-20 1993-09-07 Creative Biomolecules DNA encoding a protein which enables selective removal of immune complexes
US5084398A (en) * 1987-11-20 1992-01-28 Creative Biomolecules Selective removal of immune complexes
ATE91152T1 (de) * 1988-07-22 1993-07-15 Imre Corp Gereinigte protein a-zusammensetzungen und verfahren zu ihrer herstellung.
WO1993002107A1 (fr) * 1991-07-25 1993-02-04 Oriental Yeast Co., Ltd. Proteine artificielle de combinaison avec les immunoglobulines
GB9823071D0 (en) * 1998-10-21 1998-12-16 Affibody Technology Ab A method
SE0301936D0 (sv) * 2003-06-30 2003-06-30 Affibody Ab New polypeptide
SE0400501D0 (sv) 2004-02-27 2004-02-27 Amersham Biosciences Ab Antibody purification
NZ548126A (en) 2004-02-27 2009-10-30 Ge Healthcare Bio Sciences Ab A process for the purification of antibodies involving addition of a second resin
JP5064225B2 (ja) 2004-10-21 2012-10-31 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ 抗体精製法
US20080220968A1 (en) 2005-07-05 2008-09-11 Ge Healthcare Bio-Sciences Ab [1, 2, 4] Triazolo [1, 5-A] Pyrimidine Derivatives as Chromatographic Adsorbent for the Selective Adsorption of Igg
CA2666053C (en) 2006-12-06 2011-03-29 Repligen Corporation Nucleic acids encoding recombinant protein a
US8592555B2 (en) 2008-08-11 2013-11-26 Emd Millipore Corporation Immunoglobulin-binding proteins with improved specificity
SG195555A1 (en) 2008-12-24 2013-12-30 Emd Millipore Corp Caustic stable chromatography ligands
SG186552A1 (en) 2011-06-08 2013-01-30 Emd Millipore Corp Chromatography matrices including novel staphylococcus aureus protein a based ligands
MY178616A (en) 2012-09-17 2020-10-19 Grace W R & Co Chromatography media and devices
SG11201605712SA (en) 2014-01-16 2016-08-30 Grace W R & Co Affinity chromatography media and chromatography devices

Also Published As

Publication number Publication date
SE462046C (sv) 1998-04-27
JPH0755153B2 (ja) 1995-06-14
DE3390105C2 (OSRAM) 1993-01-07
DE3390105T1 (de) 1984-10-18
WO1984000773A1 (en) 1984-03-01
JPS59501693A (ja) 1984-10-11
SE8204810D0 (sv) 1982-08-23
SE462046B (sv) 1990-04-30

Similar Documents

Publication Publication Date Title
SE8204810L (sv) Hybrid-dna-molekyl, transformerad mikroorganism och sett att framstella protein a
FI840090L (fi) Hybridproteiner.
NO157480C (no) Hybridmodus hornantenne.
FI863269A7 (fi) Fjaedrande och svaengbar styrrulle.
FI863612A7 (fi) Kreditarrangemang foer ett kommunikationsnaet.
ATE118528T1 (de) Brennstoffabrikate.
FI854020A0 (fi) Stol.
FI860654A0 (fi) Laodabildande hoernelement och en laoda innehaollande ett saodant.
FI862653L (fi) Bensinblandning.
FI831420L (fi) Tricykliska foereningar, deras framstaellning, anvaendning och mellanprodukter
FI882746A0 (fi) Hybridprotein c och foerfarande foer dess framstaellning.
FI864305A0 (fi) Stol utan ryggstoed.
FI875324L (fi) Hybridproteiner.
FR2564854B1 (fr) Photobioreacteur.
FI863704A0 (fi) Foerbaettringar betraeffande viraliska isolater och deras anvaendning.
FI864318A0 (fi) Kopplingsanordning foer ett oeverspaenningskydd i elektroniska telefonstationer.
FI872921A0 (fi) Ett mikrobhaerlett vaexters tillvaext befraemjande aemne och utbytet oekande aemne.
DE3586765D1 (de) Immunogenische hav-peptide.
IT8620740A0 (it) Collettore di carburante.
DE3672622D1 (de) Ordner.
NO164406C (no) Stablebart brett.
FI881268L (fi) Hybridserpiner och dessa kodande dna:n.
FI864329A7 (fi) 1-metyl-15 -alkylandrosta-1,4-dien -3,17-dioner foerfaranden foer deras framstaellning och laekemedelspreparat innehaollande dessa.
DE3669053D1 (de) Beschleunigungsaufnehmer.
IT8321508A0 (it) Preparazione fermentativa dil.-leucina.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8204810-9